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Abstract
Endogenously expressed human canonical transient receptor potential 1 (hTRPC1) and human canonical transient receptor potential 6
(hTRPC6) have been shown to play a role in store-operated Ca2+ entry (SOCE) in human platelets, where two mechanisms for SOCE, regulated
by the dense tubular system (DTS) or the acidic granules, have been identified. In cells preincubated for 1 min with 100 µM flufenamic acid we
show that hTRPC6 is involved in SOCE activated by both mechanisms, as demonstrated by selective depletion of the DTS or the acidic stores,
using thapsigargin (TG) (10 nM) or 2,5-di-(tert-butyl)-1,4-hydroquinone (TBHQ) (20 µM), respectively, although it is more relevant after acidic
store depletion. Co-immunoprecipitation experiments indicated that depletion of both stores separately results in time-dependent interaction
between hTRPC1 and hTRPC6, and also between both hTRPCs and the type II IP3 receptor (IP3RII). The latter was greater after treatment with
TG. TBHQ-induced coupling between hTRPC1 and 6 was transient and decreased after 30s of treatment, while that induced by TG increased for
at least 3 min. TBHQ induced association between SERCA3, located in the acidic stores, hTRPC1, hTRPC6 and Orai1. TBHQ also evoked
coupling between SERCA3 and IP3RII, presumably located in the DTS, thus suggesting interplay between both Ca
2+ stores. Similarly, TG induces
the interaction of SERCA2b with hTRPC1 and 6 and the IP3RII. The interactions between hTRPC1, hTRPC6, IP3RII and SERCA3 were impaired
by disruption of the microtubules, supporting a role for microtubules in Ca2+ homeostasis. In conclusion, the present data demonstrate for the first
time that hTRPC1, hTRPC6, IP3RII and SERCA3 are parts of a macromolecular protein complex activated by depletion of the intracellular Ca
2+
stores in human platelets.
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Ca2+ signalling plays a key role in many essential cell
processes, including secretion, muscle contraction, platelet ag-
gregation, gene transcription and cell proliferation, where store-
operated Ca2+ entry (SOCE) is very relevant [1]. Members ofAbbreviations: BSA, bovine serum albumin; [Ca2+]c, cytosolic free calcium
concentration; DTS, dense tubular system; HBS, HEPES-buffered saline;
hTRPC1, human canonical transient receptor potential 1; hTRPC6, human
canonical transient receptor potential 6; IP3, inositol 1,4,5-trisphosphate; IP3R,
IP3 receptor; TBHQ, 2,5-di-(tert-butyl)-1,4-hydroquinone; TG, thapsigargin
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doi:10.1016/j.bbamcr.2007.12.008the TRP family are involved in Ca2+ entry into cells in response
to a variety of different stimuli [2,3]. The TRP superfamily is
divided into seven subfamilies: the five group 1 TRPs (TRPC,
TRPV, TRPM, TRPN, and TRPA) and two group 2 subfamilies
(TRPP and TRPML) [4]. TRP channel subunits assemble into
homo- or heterotetrameric channel complexes, whose subunit
composition presumably influences the biophysical and
regulatory properties of the resulting channel [5]. The canonical
transient receptor potential (TRPC) cation channels are mam-
malian homologues of the photoreceptor TRP channel in
Drosophila melanogaster that play a relevant role in Ca2+ entry
pathways, [6–10]. TRPC1, the first mammalian TRPC protein
to be identified, has been reported as a component of the store-
Fig. 1. Effect of flufenamic acid and microtubular remodelling on TBHQ-induced SOCE in human platelets. Fura-2-loaded human platelets were preincubated for
1 min with 100 µM flufenamic acid or the vehicle, as control, in the absence or presence of 30 µM colchicine or 10 µM paclitaxel, as indicated. Cells were stimulated in
a Ca2+-free medium (100 µM EGTAwas added) with 20 µM TBHQ followed by addition of CaCl2 (final concentration 300 μM; C–D, or 500 µM; A–B) 3 min later to
initiate Ca2+ entry. In the presence of flufenamic acid (panels A and B) elevations in [Ca2+]c were monitored using the 340/380 nm fluorescence ratio. In the absence of
flufenamic acid (panels B and D) the 340/380 nm fluorescence ratio were calibrated in terms of [Ca2+]c as described in the Materials and methods section. Histograms
represent Ca2+ entry under different conditions and are expressed as fold increase over control (cells not treated with flufenamic acid, colchicine or paclitaxel). Ca2+
entry was determined as described in the Materials and methods section. Values are means±S.E.M. of 5–7 independent experiments; significance values indicate
differences compared to control. ⁎⁎pb0.01.
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salivary gland, keratinocytes, smooth, skeletal, and cardiac muscle,
DT40, HEK293, neuronal, intestinal, endothelial cells and human
platelets (for a review see [11]). On the other hand, TRPC6, which
has been reported to be regulated by several signals, including
the second messenger diacylglycerol, tyrosine or serine phospho-
rylation, phosphatidylinositol 4,5-bisphosphate (PIP2) and Ca
2+
store depletion [12,13], has been suggested to play a number of
physiological roles given its specific expression [14].TRPC channels have been shown to be organized into su-
pramolecular signalling complexes, including intracellular re-
ceptors, such as inositol 1,4,5-trisphosphate (IP3) and ryanodine
receptors, and adaptor proteins in native tissues [15–19]. In
human platelets, hTRPC1, hTRPC4 and hTRPC5, as well as
hTRPC3 and hTRPC6 form heteromultimers with different
biochemical properties [20]. In these cells hTRPC1 has been
found to form reversible complexes with the type II IP3 receptor
(IP3RII) and intracellular Ca
2+ sensor STIM1 regulated by the
Fig. 2. Effect of flufenamic acid and microtubular remodelling on TG-induced SOCE in human platelets. Fura-2-loaded human platelets were preincubated for 1 min with
100 µM flufenamic acid or the vehicle, as control, in the absence or presence of 30 µM colchicine or 10 µM paclitaxel, as indicated. Cells were stimulated in a Ca2+-free
medium (100 µMEGTAwas added) with 10 nMTG followed by addition ofCaCl2 (final concentration 300μM;C–D, or 500 µM;A–B) 3min later to initiate Ca
2+ entry. In
the presence of flufenamic acid (panels A and B) elevations in [Ca2+]c were monitored using the 340/380 nm fluorescence ratio. In the absence of flufenamic acid (panels
C and D) the 340/380 nm fluorescence ratio were calibrated in terms of [Ca2+]c as described in the Materials and methods section. Histograms represent Ca
2+ entry under
different conditions and are expressed as fold increase over control (cells not treatedwith flufenamic acid, colchicine or paclitaxel). Ca2+ entrywas determined as described in
the Materials and methods section. Values are means±S.E.M. of 4 independent experiments; significance values indicate differences compared to control. ⁎⁎pb0.01 and
⁎⁎⁎pb0.001.
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modulated by the microtubules, which play a regulatory role in
the formation of TRPC signalling complexes [24].
Two mechanisms for SOCE in human platelets have been
identified, regulated by separate Ca2+ compartments: the dense
tubular system (DTS) and acidic stores [25]. Human platelets
express SERCA2b and different isoforms of SERCA3 [26,27]:
SERCA2b is expressed in the DTS and shows a high sensiti-
vity to TG and is insensitive to TBHQ; in contrast, SERCA3,
a TBHQ-sensitive SERCA isoform with low affinity for TG
[28–31], has been identified in the acidic organelles. Both
mechanisms for SOCE are modulated by the actin cytoskele-
ton and microtubules. The latter facilitates SOCE mediated bydepletion of the acidic stores while it plays a negative regula-
tory role in SOCE activated by the DTS [24]. Hence, we have
investigated the formation of signalling complexes associated
with TRPC1 and TRPC6 channel subunits activated by se-
lective depletion of the DTS or the acidic stores and their
regulation by microtubules in human platelets.
2. Materials and methods
2.1. Materials
Fura-2 acetoxymethyl ester (fura-2/AM) was from Molecular Probes
(Leiden, The Netherlands). Apyrase (grade VII), aspirin, thapsigargin (TG),
paclitaxel, colchicine, flufenamic acid and bovine serum albumin (BSA) were
Fig. 3. Microtubules are involved in the coupling between hTRPC1 and the type
II IP3R stimulated by selective depletion of the DTS or the acidic stores in
human platelets. Human platelets were treated with 20 µM TBHQ (A), 10 nM
TG (B) or the vehicles, as controls (Non-stimulated) and then lysed. Whole-cell
lysates were immunoprecipitated (IP) with anti- IP3RII antibody. Immunopre-
cipitates were analysed by Western blotting (WB) using anti-hTRPC1 antibody
(top panel) or anti-IP3RII antibody (bottom panel) as described in the Materials
and methods section. Positions of molecular-mass markers are shown on the
right. These results are representative of 4–7 independent experiments.
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(TBHQ) were from Axxora (Nottingham, U.K.). Anti-hTRPC1 and anti-
hTRPC6 polyclonal antibodies were from Alomone Laboratories (Jerusalem,
Israel). Anti-IP3R type II polyclonal antibody and horseradish-peroxidase-
conjugated donkey anti-goat IgG antibody were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, U.S.A.). Anti-Orai1 antibody was from ProSci
Inc (Poway, CA, U.S.A.). Anti-SERCA2b antibody (IID8) and anti-SERCA3
antibody (ab3339) were from Abcam plc. (Cambridge, UK). Anti-SERCA3 (PL/
IM430) antibody was generously provided by Dr. J. Enouf (INSERM, Paris,
France). Horseradish-peroxidase-conjugated goat anti-rabbit IgG antibody,
horseradish-peroxidase-conjugated sheep anti-mouse IgG antibody and high
range molecular weight markers were purchased from Upstate (Cambridge,
UK). All other reagents were of analytical grade.
2.2. Platelet preparation
Fura-2-loaded platelets were prepared as previously described [31] as ap-
proved by Local Ethical Committees and in accordance with the Declaration of
Helsinki. Briefly, blood was obtained from healthy drug-free volunteers and
mixed with one-sixth volume of acid/citrate dextrose anticoagulant containing
(in mM): 85 sodium citrate, 78 citric acid and 111 D-glucose. Platelet-rich plasma
(PRP) was then prepared by centrifugation for 5 min at 700×g and aspirin
(100 µM) and apyrase (40 µg/mL) were added. Platelet-rich plasma was in-
cubated at 37 °C with 2 µM fura-2 acetoxymethyl ester for 45 min. Cells were
then collected by centrifugation at 350×g for 20 min and resuspended in HEPES-
buffered saline (HBS), pH 7.45, containing (in mM): 145NaCl, 10 HEPES, 10 D-
glucose, 5 KCl, 1 MgSO4 and supplemented with 0.1% BSA and 40 µg/mL
apyrase.
2.3. Measurement of cytosolic free calcium concentration ([Ca2+]c)
Fluorescence was recorded from 2 mL aliquots of magnetically stirred
platelet suspension (2 × 108cells/mL) at 37 °C using a fluorescence spectro-
photometer with excitation wavelengths of 340 and 380nm and a 505nm long-
pass filter to collect the emitted fluorescence. Changes in [Ca2+]c were moni-
tored using the fura-2 340/380 fluorescence ratio and calibrated according to
the method of Grynkiewicz et al. [32]. It was not possible to calibrate traces
when flufenamic acid was present because of its effect on fura-2 fluorescence and
the data obtained with this agent are presented as fura-2 340/380 fluorescence
ratio.
Ca2+ release and entry stimulated by TG or TBHQ were estimated using
the integral of the rise in [Ca2+]c or the fura-2 340/380 fluorescence ratio for
2 or 3 min, respectively, after the addition of the stimulus or 300 µM (final
concentration) CaCl2 to the extracellular medium, respectively, and were ex-
pressed as nM.s, as previously described [22].
2.4. Immunoprecipitation and Western blotting
Aliquots of platelet suspension (250µL; 4 × 108cells/mL) were lysed by
mixing with an equal volume of 2× lysis buffer, pH 7.2, containing 316 mM
NaCl, 20 mM Tris, 2 mM EGTA, 0.2% SDS, 2% sodium deoxycholate, 2%
Triton X-100, 2 mM Na3VO4, 2 mM phenylmethylsulfonyl fluoride, 100 µg/ml
leupeptin, and 10 mM benzamidine [21]. Aliquots (0.5 mL) were then im-
munoprecipitated by incubation with 1.5 µg/mL anti-IP3R type II antibody, anti-
SERCA 3 antibody, anti-hTRPC6 or anti-Orai1 antibody and protein A-agarose
overnight at 4 °C [33]. Immunoprecipitates were resolved by 8% SDS-PAGE,
and separated proteins were transferred onto nitrocellulose membranes. Im-
munodetection of hTRPC1, TRPC6, IP3RII, SERCA3 and Orai1 was achieved
using the anti-hTRPC1 or anti-hTRPC6 antibody diluted 1:200 in TBST for
2h, anti- IP3RII or anti-SERCA3 (ab3339 or PL/IM430) diluted 1:500 in TBST
for 2h and anti-Orai1 antibody diluted 1:1000 in TBST for 2h. To detect the
primary antibody, membranes were incubated with the appropriate secon-
dary antibody diluted 1:5000 in TBST supplemented with 1% BSA for 1h.
Membranes were then incubated with enhanced chemiluminescence (ECL)
reagents for 5 min. Blots were then exposed to photographic film. Membrane
reprobing for protein loading control was performed by removing bound
antibodies by incubation for 30 min at 50 °C with stripping buffer containing100 mM 2-mercaptoethanol, 65.5 mM Tris and 2% SDS, pH 6.7, followed
by Western blotting with the antibodies used for the immunoprecipitation.
Quantification of coupling between the different proteins was determined by
using scanning optical densitometry.
2.5. Reversible electroporation procedure
The platelet suspension was transferred to an electroporation chamber
containing antibodies at a final concentration of 2 µg/mL, and the antibo-
dies were transjected according to published methods [13,23]. Reversible elec-
tropermeabilization was performed at 4kV/cm at a setting of 25-microfarad
capacitance and was achieved by 7 pulses using a Bio-Rad Gene Pulser Xcell
Electroporation System (Bio-Rad, Hercules, CA, U.S.A.). Following electro-
poration, cells were incubated with antibodies for an additional 60 min at 37 °C
then were centrifuged at 350×g for 20 min and resuspended in HBS containing
200 µM CaCl2.
2.6. Statistical analysis
Analysis of statistical significance was performed using one-way analy-
sis of variance. For comparison between two groups Student's t-test was used.
p b 0.05 was considered significant.
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3.1. Effects of flufenamic acid and microtubular remodelling
on TBHQ- and TG-induced SOCE in human platelets
Previous studies by us have demonstrated that both hTRPC1
and hTRPC6 proteins are involved in the conduction of Ca2+
during the activation of SOCE by depletion of the acidic sto-
res, using TBHQ, or the DTS, using a low concentration of
TG (10 nM) [13]. Flufenamic acid is a non-steroidal anti-in-
flammatory drug known to increase TRPC6 currents but to
inhibit currents mediated by other TRPC channels, especially
the TRPC3/7 subfamily and TRPC5 at 100 µM [34–36]. We
have now used flufenamic acid to investigate the relevance
of hTRPC1 and hTRPC6 in SOCE mediated by TBHQ or TG.
In the absence of extracellular Ca2+ (100 µM EGTAwas added),
treatment of fura-2-loaded human platelets in stirred cuvettes
at 37 °C with 20 µM TBHQ induced a sustained increase in
[Ca2+]c. Subsequent addition of Ca
2+ to the extracellular me-
dium (500 µM) resulted in a rapid rise in [Ca2+]c indicative ofFig. 4. Colchicine impairs coupling between hTRPC6 and the type II IP3R stimulated
platelets were preincubated for 30 min in the presence of 30 µM colchicine (Col
(A), 10 nM TG (B) for several times (30 s–3 min) or the vehicles, as controls (NS) an
antibody. Immunoprecipitates were analysed by Western blotting (WB) using anti-hT
molecular-mass markers are shown on the right. Results are expressed as percentage o
E.M. of 4–5 separate experiments.Ca2+ entry (Fig. 1A). Treatment of platelets with 100 µM of
flufenamic acid for 1 min did not significantly modify TBHQ-
induced Ca2+ release or entry (TBHQ-induced Ca2+ entry in the
presence of flufenamic acid was 1.04 ± 0.05-fold increase as
compared to control; mean ± S.E.M.; Student's t-test; n = 5). In
contrast pretreatment with flufenamic acid significantly reduced
SOCE induced by (10 nM)TGby36.8±1.5%(Fig. 2A;pb 0.001;
n = 4).
We have recently reported that the microtubule disrupter
colchicine reduced SOCE activated by TBHQ but enhanced
SOCE activated by TG while paclitaxel, which stabilizes mi-
crotubules, exerted opposite effects [37]. Platelet incubation
with 30 µM colchicine, for 30 min at 37 °C, reduced TBHQ-
induced Ca2+ entry by 13.3 ± 3.5% (Fig. 1C; p b 0.01; n = 6). In
the presence of flufenamic acid, the inhibitory effect of col-
chicine on TBHQ-induced Ca2+ entry was significantly en-
hanced to 37.2 ± 4.5% (Fig. 1B; p b 0.01; n = 5). As shown in
Fig. 2C, pretreatment with colchicine enhanced TG-induced
SOCE by 15.1 ± 5.5% (Fig. 2C; p b 0.01; n = 7); however, in
the presence of flufenamic acid, colchicine reduced TG-inducedby selective depletion of the DTS or the acidic stores in human platelets. Human
chicine) or the vehicle (Control). Cells were then treated with 20 µM TBHQ
d then lysed. Whole-cell lysates were immunoprecipitated (IP) with anti-IP3RII
RPC6 antibody as described in the Materials and methods section. Positions of
f control (resting cells not treated with colchicine) and are presented as means±S.
Fig. 5. Colchicine impairs coupling between hTRPC1 and hTRPC6 stimulated by selective depletion of the DTS or the acidic stores in human platelets. Human
platelets were preincubated for 30 min in the presence of 30 µM colchicine (Colchicine) or the vehicle (Control). Cells were then treated with 20 µM TBHQ
(A), 10 nM TG (B) for several time periods (30 s–3 min) or the vehicles, as controls (NS) and then lysed. Whole-cell lysates were immunoprecipitated (IP) with anti-
hTRPC6 antibody. Immunoprecipitates were analysed by Western blotting (WB) using anti-hTRPC1 antibody as described in the Materials and methods section.
Positions of molecular-mass markers are shown on the right. Results are expressed as percentage of control (resting cells not treated with colchicine) and are presented
as means±S.E.M. of 5–7 separate experiments.
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previously reported, paclitaxel enhanced TBHQ-induced SOCE
but exerted opposite effects on TG-activated SOCE (Figs. 1 and
2, panel D). Platelet incubation with 10 µM paclitaxel, for
30 min at 37 °C, in the presence of flufenamic acid did not alter
TBHQ-induced SOCE (Fig. 1B) but enhanced TG-activated
SOCE by 7.9 ± 3.5% (Fig. 2B; p b 0.05; n = 4).
3.2. Microtubules are involved in the coupling between
hTRPC1 and the type 2 IP3 receptor induced by TBHQ and TG
We have previously demonstrated by co-immunoprecipita-
tion coupling between hTRPC1 and IP3RII in human plate-
lets stimulated by thrombin or following extensive depletion
of the intracellular Ca2+ stores [21,22,38]. Hence we have now
investigated the activation of the coupling between hTRPC1
and IP3RII by depletion of the acidic stores or the DTS se-
parately. Immunoprecipitation and subsequent SDS-PAGE
and Western blotting were conducted using control plate-lets and platelets in which each intracellular Ca2+ store had
been depleted by 3 min of pretreatment with TBHQ (20 µM;
Fig. 3A), to deplete the acidic stores, or TG (10 nM; Fig. 3B) to
discharge the DTS in the absence of extracellular Ca2+ (100 µM
EGTA). After immunoprecipitation with the anti-IP3RII an-
tibody, Western blotting revealed the presence of hTRPC1 in
samples from store-depleted, but not control platelets (Fig. 3,
top panels; n = 4–6), as previously reported [21,22]. Western
blotting with anti-IP3RII confirmed a similar content of this
protein in all lanes (Fig. 3, bottom panels).
Platelet incubation with 10 µM paclitaxel enhanced TBHQ-
induced coupling by 26.7 ± 9.7% (Fig. 3A; p b 0.01; n = 6), but
reduced that stimulated by depletion of the DTS with 10nM
TG by 26.0 ± 6.1% (Fig. 3B; p b 0.01; n = 7). In contrast,
colchicine induced basically opposite effects, enhancing the
coupling between hTRPC1 and IP3RII induced by TG by 28.6 ±
9.5% while reducing the coupling induced by TBHQ by 13.1 ±
3.5% (Fig. 3; p b 0.05; n = 4–6). Neither paclitaxel nor col-
chicine induced coupling between hTRPC1 and IP3RII per se.
Fig. 6. Colchicine impairs the interaction of SERCA3 with hTRPC1 and 6 and the type II IP3 receptor stimulated by selective depletion of the acidic stores in human
platelets. Human platelets were preincubated for 30 min in the presence of 30 µM colchicine (Colchicine) or the vehicle (Control). Cells were then treated with 20 µM
TBHQ for several time periods (30 s–3 min) or the vehicles, as controls (NS) and then lysed. Whole-cell lysates were immunoprecipitated (IP) with anti-SERCA3
antibody (A and B) or anti-IP3RII antibody (C). Immunoprecipitates were analysed by Western blotting (WB) using anti-hTRPC1 (A), anti-hTRPC6 (B) or anti-
SERCA3 (C) antibodies as described in the Materials and methods section. Positions of molecular-mass markers are shown on the right. Results are expressed as
percentage of control (resting cells not treated with colchicine) and are presented as means±S.E.M. of 4–7 separate experiments.
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hTRPC6 and the type 2 IP3 receptor
We have further investigated whether store depletion ac-
tivates interaction between hTRPC6 and IP3RII by co-im-
munoprecipitation of platelet lysates. Immunoprecipitation and
subsequent SDS-PAGE and Western blotting were conducted
using control platelets and platelets treated with 20 µM TBHQ
or 10 nM TG for 30 s, 1 min and 3 min. After immunoprecipi-
tation with the anti- IP3RII antibody, Western blotting revea-
led the presence of hTRPC6 in samples from control platelets,
which was enhanced after stimulation with TBHQ or TG in atime-dependent manner for at least 3 min (Fig. 4; n = 5). Western
blotting with anti-IP3RII confirmed a comparable amount of
protein in all lanes (data not shown). Platelet incubation with
30 µM colchicine did not significantly modify the coupling
between hTRPC6 and IP3RII in resting cells but impaired the
response to TBHQ and TG (Fig. 4; n = 4).
3.4. Time course of TBHQ- or TG-induced coupling between
hTRPC1 and hTRPC6
hTRPC1, hTRPC3, hTRPC4, hTRPC5 and hTRPC6 have
been shown to be expressed in human platelets, where hTRPC1,
Fig. 7. Electrotransjection of anti-SERCA3 antibody (PL/IM430) attenuates
the interaction of the type II IP3 receptor with hTRPC1 and hTRPC6. Human
platelets (109 cells/mL) were electropermeabilized in a Gene Pulser as descri-
bed in Material and methods. Following electroporation, cells were incubated
in the absence (−) or presence of 2 µg/mL anti-SERCA3 (PL/IM430) antibody
(α-SERCA) or mouse anti-IgG (m-IgG), as indicated, for an additional 60 min at
37 °C, centrifuged at 350 ×g for 20 min and resuspended in HBS containing
200 µM CaCl2. At the time of experiment 250 µM EGTA was added. Human
platelets were treated with 20 µM TBHQ or the vehicle, as control, and then
lysed. Whole-cell lysates were immunoprecipitated (IP) with anti- IP3RII an-
tibody. Immunoprecipitates were analysed by Western blotting (WB) using anti-
hTRPC1 antibody (A, top panel), anti-hTRPC6 antibody (B, top panel) or anti-
IP3RII antibody (A and B, bottom panels) as described in the Materials and
methods section. Positions of molecular-mass markers are shown on the right.
These results are representative of 6 independent experiments.
Fig. 8. Thrombin induces interaction between SERCA3 and Orai1 in human
platelets. Human platelets were stimulated with 1 U/mL thrombin for several
time periods (10 s–60 s) or left untreated (Control) and then lysed. Whole-cell
lysates were immunoprecipitated (IP) with anti-Orai1 antibody. Immunopreci-
pitates were analysed by Western blotting (WB) using anti-SERCA3 (PL/
IM430) antibody (top panel) and reprobed with anti-Orai1 antibody (lower
panel) as described in the Materials and methods section. Positions of molecular-
mass markers are shown on the right. Results are expressed as percentage of
control (resting cells) and are presented as means±S.E.M. of 6 separate
experiments.
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and hTRPC6 [20]. Since hTRPC1 and hTRPC6 are invol-
ved in SOCE in human platelets [7,12] and both associate
with the IP3RII, we have further explored the possibility that
both channels interact forming a heteromultimer. We therefore
tested for coupling between hTRPC1 and 6 by looking for co-
immunoprecipitation from platelet lysates. Immunoprecipita-
tion and subsequent SDS-PAGE and Western blotting were
conducted using control platelets and platelets treated with
20 µM TBHQ or 10 nM TG for 30 s, 1 min and 3 min in theabsence of extracellular Ca2+ (100 µM EGTA). Treatment of
platelets with TBHQ induced a transient increase in the cou-
pling between hTRPC1 and hTRPC6 in a time-dependent
manner, reaching a maximum after 30s of stimulation and
then returning to basal levels (Fig. 5A; n = 7). Platelet sti-
mulation with 10nM TG induced a time-dependent increase
of the interaction between both hTRPC proteins, which was
found to be slower and more sustained than that induced
by TBHQ (Fig. 5B; n = 5). Western blotting with anti-
hTRPC6 confirmed a comparable amount of protein in all
lanes (Fig. 5).
As reported for the interaction between hTRPC6 and IP3RII,
pretreatment for 30 min with 30 µM colchicine did not sig-
nificantly modify the coupling between hTRPC1 and 6 in res-
ting cells, but abolished the effects of TBHQ and TG (Fig. 5;
n = 5–7).
Fig. 9. Colchicine impairs the interaction of SERCA2b with hTRPC1 and 6 and the type II IP3 receptor stimulated by selective depletion of the DTS in human
platelets. Human platelets were preincubated for 30 min in the presence of 30 µM colchicine (Colchicine) or the vehicle (Control). Cells were then treated with 10 nM
TG for several time periods (1–3 min) or the vehicle, as controls (NS) and then lysed. Whole-cell lysates were immunoprecipitated (IP) with anti-SERCA2b
antibody (A and B) or anti-IP3RII antibody (C). Immunoprecipitates were analysed by Western blotting (WB) using anti-hTRPC1 (A), anti-hTRPC6 (B) or anti-
SERCA2b (C) antibodies as described in the Materials and methods section. Positions of molecular-mass markers are shown on the right. Results are expressed as
percentage of control (resting cells not treated with colchicine) and are presented as means±S.E.M. of 6 separate experiments.
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hTRPC6 and the type II IP3 receptor in human platelets
A role for SERCA in the modulation of SOCE has been
recently described in HEK-293 cells, where TRPC7 and TRPC3
are regulated by SERCA due to its ability to reduce the high Ca2+
microdomains generated after channel opening, which suggest
the relevance of functional protein complexes, involving Ca2+
channels, Ca2+ ATPases and other enzymes and regulatory mo-
lecules, in SOCE [39]. SERCA3 has been reported to be pre-
sent in the acidic stores [28–31], which we have previously
suggested to be located in the cell periphery on the basis of theirinteraction with the plasma membrane and its regulation by
the actin cytoskeleton [25]. Thus, we have investigated the
possible interaction of SERCA3 with hTRPC1 and hTRPC6
after platelet stimulation with TBHQ, which selectively depletes
the acidic stores by inactivation of SERCA3. Co-immunopre-
cipitation of platelet lysates with anti-SERCA3 (ab3339) an-
tibody followed by Western blotting with anti-hTRPC1 or anti-
hTRPC6 antibodies reported a detectable interaction between
SERCA3 and both channel subunits in resting cells (Fig. 6A
and B). This interaction was significantly enhanced by TBHQ,
which induced a transient increase in the coupling between
SERCA3 and hTRPC1, reaching a maximum after 1 min of
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the other hand, TBHQ induced a sustained increase in the
interaction between SERCA3 and the hTRPC6 protein reaching
a maximum after 3 min of treatment (Fig. 6B; n = 4). We further
investigated the association of SERCA3 with the IP3RII by co-
immunoprecipitation of platelet lysates with the anti-IP3RII
antibody followed by Western blotting with the anti-SERCA3
antibody. As shown in Fig. 6C, treatment with TBHQ induced
interaction between SERCA3 and IP3RII reaching a maximum
after 1 min of treatment. These findings suggest that depletion of
the acidic stores enhances the interaction between SERCA3,
IP3RII and the channel subunits hTRPC1 and 6, an effect that
was found in the presence of TBHQ, which suggest that this
interaction does not require active SERCA3 to occur. The results
obtained with the anti-SERCA3 (ab3339) antibody were con-
firmed using the anti-SERCA3 (PL/IM430) antibody raised
against human SERCA3 (data not shown). Western blotting
with the antibodies used for immunoprecipitation confirmed a
comparable amount of protein in all lanes.
Microtubular disruption by pretreatment for 30 min with
30 µM colchicine prevented the coupling between SERCA3,
IP3RII and the channel proteins hTRPC1 and 6 induced by
TBHQ, without having any significant effect on the interactions
observed in resting cells (Fig. 6; n = 4–6).
3.6. Electrotransjection of anti-SERCA3 antibody attenuates
the interaction of the type II IP3 receptor with hTRPC1 and
hTRPC6
We have further investigated the role of SERCA3 in the
formation of the macromolecular complex involving hTRPC1
and 6, and the IP3RII. The anti-SERCA3 (PL/IM430) antibody
has been shown to inhibit SERCA3 activity by sterically pre-
venting movement of the actuator domain into a catalytically
critical position in the E2 conformation of the enzyme [40].
Electrotransjection of cells with anti-SERCA3 (PL/IM430) an-
ibody significantly reduced the interaction between hTRPC1
and IP3RII induced by TBHQ by 43% as detected by coim-
munoprecipitation (Fig. 7; p b 0.05; n = 6). In addition,
electrotransjection of cells with anti-SERCA3 antibody sig-
nificantly reduced the interaction between hTRPC6 and IP3RII
stimulated by treatment with TBHQ by 37% (Fig. 7; p b 0.05;
n = 6). Electrotransjection of a mouse IgG, of the same nature as
the anti-SERCA3 antibody, did not significantly modify the
resting or TBHQ-evoked interaction of IP3RII with any of the
hTRPC channels investigated (Fig. 7). These findings suggest
that SERCA3 is required for the formation of the macro-
molecular complex activated by depletion of the acidic stores in
human platelets.
3.7. SERCA3 interacts with Orai1 after stimulation with
thrombin in human platelets
Recent studies have identified the protein Orai1 as an
essential component in SOCE [41,42], and a dynamic assembly
between hTRPC1, STIM1 and Orai1 has been shown to be
involved in activation of SOC channels in response to depletionof internal Ca2+ stores [43]. We have now investigated the
possible interaction between Orai1 and SERCA3 in human
platelets. Co-immunoprecipitation of platelet lysates with anti-
Orai1 antibody followed byWestern blotting with anti-SERCA3
(PL/IM430) antibody reported a detectable interaction between
SERCA3 and Orai1 in resting cells (Fig. 8). This interaction
was significantly enhanced by treatment with thrombin, which
releases Ca2+ from both intracellular stores in human plate-
lets, the DTS and the acidic stores [44]. Thrombin induced a
time-dependent increase in the interaction between Orai1 and
SERCA3, reaching a maximum after 1 min of stimulation
(Fig. 8; n = 6).
3.8. TG induces interaction of SERCA2b with hTRPC1,
hTRPC6 and the type II IP3 receptor
We have further explored by coimmunoprecipitation the
interaction of SERCA2b, located in the DTS [28,31], with
hTRPC1 and 6 and IP3RII in platelets after selective discharge of
the DTS using 10 nM TG. As shown in Fig. 9, platelet treat-
ment with TG induces a transient increase in the interaction
of SERCA2b with the hTRPC proteins 1 and 6 and the IP3RII,
reaching a maximum after 1 min of stimulation, and then
returned to basal levels (Fig. 9A–C; n = 6). Pretreatment for
30 min with 30 µM colchicine abolished the coupling between
SERCA2b, IP3RII and the channel proteins hTRPC1 and 6
induced by TG, (Fig. 9; n = 6). Western blotting with the
antibodies used for immunoprecipitation confirmed a compar-
able amount of protein in all lanes. These findings suggest that
depletion of the DTS induces the formation of a complex
involving SERCA2b, IP3RII and hTRPC1 and 6, which was
not dependent on SERCA2b activity, since it was found in
the presence of TG. This event requires the integrity of the
microtubules, which might support the interaction between
the cellular membranes where these proteins are located.
4. Discussion
Over a decade has passed since the identification of the
mammalian TRPC superfamily of channels [45]. TRPC proteins
are thought to assemble with other TRP proteins as homo or
heterotetramers to form cation channels, although the functional
properties of every single tetramer have not been explored to
date. In addition, all TRPC proteins possess binding sites for a
number of regulatory proteins, such as the overlapping bind-
ing sites for calmodulin and the IP3 receptor, which raises the
possibility of modulation of TRPC channel function by a num-
ber of proteins belonging to the Ca2+ signalling machinery of
the cell [46]. The interaction of TRPCs with other proteins might
be the determinant for the different properties of the resulting
channels. In particular hTRPC1 and hTRPC6 have been shown
to function as store-operated and receptor-operated channels
[11,47,48] and even a stretch activated channel function has
been reported for hTRPC1 [49]. In human platelets, hTRPC1
and hTRPC6 have been reported to play a role in SOCE
[7,13,21]. Here we demonstrate that selective depletion of the
intracellular Ca2+ stores in human platelets, the DTS (depleted
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stores (discharged by TBHQ [31]), induces the formation of
heteromeric complexes between hTRPC1 and hTRPC6 and
the interaction of both hTRPC1 and hTRPC6 with the Ca2+
handling proteins IP3R type II, SERCA2b and SERCA3, which
has been shown to be present in the DTS and the acidic stores,
respectively [28,31].
The cation channel blocker flufenamic acid has been wide-
ly used to reversibly enhance currents mediated by TRPC6,
whereas currents mediated by other TRPCs were inhibited by the
compound [34]. SOCE involving hTRPC6 channels might be
expected to be enhanced by flufenamic acid, while inhibition
would be expected for a mechanism involving other hTRPCs.
hTRPC6 and hTRPC1 are important for TBHQ-activated SOCE
in human platelets [13]. Here we show that flufenamic acid
does not modify SOCE mediated by TBHQ (Fig. 1A), which
confirms that SOCE activated by TBHQ involves several
hTRPC isoforms, including hTRPC6. In agreement with this, we
have found that TBHQ induces interaction between hTRPC1
and hTRPC6, and a previous study has reported that hTRPC1
forms a heteromultimer with hTRPC4 and 5 [20], which further
confirms the results obtained with flufenamic acid. The results
obtained with flufenamic acid suggest that hTRPC6 is more
relevant for SOCE stimulated by TBHQ than for TG-induced
SOCE, which was clearly inhibited by the drug. In agreement
with this, we have reported that both hTRPC1 and 6 are involved
in TG-evoked SOCE, although the relevance of hTRPC1 was
found to be greater than that of hTRPC6 [13]. The association of
hTRPC1 with hTRPC4 and hTRPC5, which has been shown to
be inhibited by flufenamic acid [36], further support the results
obtained with flufenamic acid and suggest that several hTRPCs,
probably including hTRPC1, 4, 5 and 6 are involved in TG-
evoked SOCE. Both TBHQ and TG (10 nM) induce time-
dependent coupling between the hTRPC6 protein and IP3RII,
which was found to be more relevant after stimulation with TG.
We have also noticed differences between cell stimulation with
TBHQ and TG with respect to the activation of the coupling
between hTRPC1 and hTRPC6; while the coupling between
hTRPC1 and 6 was transient after stimulation with TBHQ, with
a maximum after 30 s of treatment, the interaction induced by
TG increased for at least 3 min, which paralleled the pattern of
the interaction between hTRPC6 and IP3RII. We have recently
found that hTRPC6 is activated by store-depletion and PIP2 in
human platelets [13], as a consequence, hTRPC6 function is
expected to be transient since platelet stimulation with agonists
leads to phospholipase C activation, followed by store depletion
and, subsequently, hTRPC6 channel gating, but as PIP2 levels
decrease hTRPC6 channels become inactivated. The transient
activation of the interaction of hTRPC6 with hTRPC1 found in
platelets is consistent with its transitory channel function [13].
However, after stimulation with TG the interactions between
hTRPC6 and either IP3RII or hTRPC1 were maintained,
suggesting that although hTRPC6 channel function might be
inactivated, this protein might still work as a regulatory subunit
of the channel.
A regulatory role for SERCAs in SOCE in HEK-293 cells
has recently been reported [39]. In these cells TRPC7 andTRPC3 were shown to be regulated by SERCA due to its ability
to reduce the high Ca2+ microdomains generated after channel
opening, which result in negative feedback over the permeability
of the channel [39]. In addition, a recent study has reported the
formation of microdomains containing SOC channels on the
plasma membrane, STIM1 proteins and SERCA on the Ca2+
store involved in the transference of Ca2+ ions directly from
SOC channels to SERCA,which buffers subplasmalemmal Ca2+
ions [50]. We have found that SERCA2b and 3 negatively
regulate thrombin-evoked Ca2+ entry in human platelets by a
mechanism that might involve interaction with hTRPC1 [51].
Here we show that selective depletion of the DTS or the acidic
stores stimulates the formation of a macromolecular complex
involving SERCAs 2b and 3, respectively, hTRPC1 and
hTRPC6, which further supports the idea that SERCA is
involved in the regulation of SOCE in these cells. The interaction
of SERCA2b and SERCA3 with hTRPC1 and 6 and with the
IP3RII in the presence of their inhibitors, 10 nM TG and TBHQ,
respectively, suggest that the activity of SERCAs is not required
for the formation of the complex, although the possible function
of both SERCAs in the molecular complex, either refilling the
stores or regulating Ca2+ entry [51], requires their activity. We
found attenuation of the interaction between the IP3RII and
hTRPC1 and 6 proteins by electrotransjection of the anti-
SERCA3 (PL/IM430) antibody. Despite we could not investi-
gate the interaction of SERCA3 with these proteins using PL/
IM430 due to interference with the electrotransjected antibody,
these findings suggest that either PL/IM430 prevents SERCA3
interaction with the complex (and this is important for protein
recruitment) or PL/IM430 prevents a conformational change in
complexed SERCA3 that is relevant for the recruitment of other
proteins of the complex. The latter has been reported for the
inhibitory effect of PL/IM430 on SERCA3 activity [40]. In
addition, we have found that SERCA3 interacts with the protein
Orai1 upon stimulation with the physiological agonist thrombin,
which has been used to induce extensive depletion of both
intracellular Ca2+ stores in human platelets. This finding further
support that SERCA3 is involved in the regulation of SOCE in
these cells. Recently, we have also found interaction between
SERCA3 and STIM1 after platelet treatment with thrombin, a
process that plays a relevant role in the regulation of Ca2+ store
refilling (Lopez JJ, personal communication). These observa-
tions indicate that stimulation of platelets with Ca2+ mobilizing
agonists induce the formation of a macromolecular complex that
involves plasmamembrane Ca2+ channels, endomembrane Ca2+
channels and Ca2+-ATPases and might play a relevant role in the
modulation of SOCE and Ca2+ store replenishment.
We have also found that SERCA3 forms a complex with
IP3RII. The molecular weight of the SERCA3 isoform that
interacts with the IP3RII is approximately 114 kDa. The different
SERCA3a–3f isoforms have different molecular weights [52–
54] and are expressed in a decremental manner in platelets,
SERCA3b being expressed at a higher level than the other
isoforms that have similar molecular weight. These findings
suggest that SERCA3b might be the isoform involved in the
macromolecular complex. In human platelets, phospholipase C
inhibition impairs Ca2+ release from the DTS but not from the
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DTS [44]. In addition, cytosolic Ca2+ redistribution into the
internal stores, after depletion of the DTS and the acidic
compartments, results in Ca2+ overloading of the acidic stores
[44]. These findings, together with our present observations
showing an interaction between SERCA3 and IP3RII, suggest
that there is interplay between both Ca2+ stores in platelets,
where the acidic stores might modulate Ca2+ mobilization
mediated by IP3-generating agonists.
Microtubules and microtubule-associated proteins have been
shown to be regulated by Ca2+ and Ca2+-sensitive kinases [55].
We have demonstrated that microtubules play a dual role in
SOCE and the coupling between hTRPC1 and IP3RII in human
platelets, both acting as a physical barrier that prevents the
trafficking of portions of the DTS to the plasma membrane, and
also supporting the transport of the acidic stores towards
the plasma membrane [56]. These findings might explain the
opposite effects of colchicine, a microtubular disrupter, and
paclitaxel, which stabilizes the microtubules, on TBHQ- or TG-
induced SOCE. Colchicine prevented the interaction between
hTRPC1 and hTRPC6, as well as the coupling between hTRPC6
and IP3RII, evoked by depletion of both Ca
2+ stores. In addition,
we found that microtubule disruption by colchicine impaired
the association of SERCA3 with hTRPC1, hTRPC6 or IP3RII
stimulated by TBHQ. These findings suggest that these events
require the support of the microtubules. The role of microtubu-
les in the regulation of Ca2+ homeostasis and Ca2+-regulated
functions have also been reported in other cells types, such as
neurons, where the microtubules support the close positioning
of mitochondria to the endoplasmic reticulum [57], or CHO
cells, where Ca2+ stores expressing IP3Rs are transferred and
accumulate to the cleavage furrow by microtubule-based
motility [58].
In the presence of flufenamic acid, colchicine reduced SOCE
mediated by depletion of both stores, as reportedwhen cells were
stimulated with TBHQ alone, suggesting that hTRPC6-
mediated SOCE requires the support of the microtubules. The
inhibitory effect was found to be more relevant when cells were
stimulated with TBHQ than after treatment with TG, which
further suggest that hTRPC6 is more important for Ca2+ entry
mediated by depletion of the acidic stores. In an attempt to
identify the intracellular Ca2+ stores involved in Ca2+ mobiliza-
tion by thrombin receptors we have recently demonstrated
that thrombin completely discharges the acidic Ca2+ stores at
concentrations as low as 0.01U/mL, which is the major source
of Ca2+ at low thrombin concentration [59]. Taking together
those findings and the observations reported here, the hTRPC6
channel subunit seems to play a relevant role in the activation
of SOCE induced by low thrombin concentrations.
We hypothesize that hTRPC6 is involved in SOCE in human
platelets. This channel subunit is more relevant for SOCE
mediated by depletion of the acidic stores. Depletion of both
the DTS and the acidic organelles stimulates the formation of
Ca2+ handling macromolecular protein complexes involving
hTRPC1, hTRPC6, SERCA3, SERCA2b, Orai1 and the type II
IP3 receptor. Depletion of the acidic stores, expressing SERCA3,
induces the association between SERCA3 and IP3RII, which islikely located in the DTS, suggesting a dynamic interaction
between both Ca2+ stores in platelets. These macromolecular
complexes require the integrity of the microtubular network, and
might be important for the formation of Ca2+ microdomains
involved in the refilling of the stores, as well as in the activation
of Ca2+-dependent cellular processes, such as aggregation.
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